{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:56Z","timestamp":1789024016521,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clear cell renal cell carcinoma (ccRCC) is the most common kidney malignancy. Yet, no rapid, non-invasive biomarkers are available for diagnosis or screening. Urine represents an ideal analyte matrix due to its accessibility, low invasiveness, longitudinal sampling, and the kidney\u2019s central role in filtration. Here, we integrated proteomic, lipidomic, and metabolomic analyses of urine from ccRCC patients and controls to identify diagnostic biomarkers. Multi-omics profiling revealed urogenital metabolic dysregulation in ccRCC, including increased lipid metabolism, altered mitochondrial respiration signatures, and elevated urinary lipid content. We identified three urinary protein biomarkers: serum amyloid A1 (SAA1), haptoglobin (HP), and lipocalin 15 (LCN15). Using a parallel reaction monitoring mass spectrometry workflow, we developed a rapid and sensitive assay and combined these markers into a diagnostic UrineScore. The UrineScore achieved 0.96 in an area under the receiver operating characteristic curve analysis in the discovery cohort, and 0.95 in an independent validation cohort. Together, these results support the feasibility of multi-omics-guided urinary biomarker discovery and represent a step toward accessible diagnostic platforms for ccRCC.<\/jats:p>","DOI":"10.1038\/s44321-026-00498-2","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:03:53Z","timestamp":1786439033000},"page":"3649-3676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-8395","authenticated-orcid":false,"given":"Gustav","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-6111","authenticated-orcid":false,"given":"Ursula","family":"Lemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6430-4550","authenticated-orcid":false,"given":"Karel","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Kr\u0161\u0161\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Sakic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Novatchkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mereiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-8981","authenticated-orcid":false,"given":"Gerlinde","family":"Grabmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-1457","authenticated-orcid":false,"given":"Thomas","family":"K\u00f6cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Koglgruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Kikic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Camano P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2734-8384","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Luna Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"D\u00edez Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0071-317X","authenticated-orcid":false,"given":"Gerald N","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8483-0962","authenticated-orcid":false,"given":"Thomas","family":"Z\u00fcllig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Hagelkruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Englinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Schmidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-3777","authenticated-orcid":false,"given":"Josef M","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"498_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(23)00276-0","volume":"24","author":"L Albiges","year":"2023","unstructured":"Albiges L, Gurney H, Atduev V, Suarez C, Climent MA, Pook D, Tomczak P, Barthelemy P, Lee JL, Stus V et al (2023) Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial. Lancet Oncol 24:881\u2013891","journal-title":"Lancet Oncol"},{"key":"498_CR2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, Bernhardt OM, Gandhi T, Miladinovi\u0107 SM, Cheng L-Y, Messner S, Ehrenberger T, Zanotelli V, Butscheid Y, Escher C et al (2015) Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteom 14:1400\u20131410","journal-title":"Mol Cell Proteom"},{"key":"498_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W, Mitchell T, Montironi R, O\u2019Brien T et al (2022) Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 82:529\u2013542","journal-title":"Eur Urol"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1152\/ajplegacy.1976.231.2.627","volume":"231","author":"M Burg","year":"1976","unstructured":"Burg M, Patlak C, Green N, Villey D (1976) Organic solutes in fluid absorption by renal proximal convoluted tubules. Am J Physiol 231:627\u2013637","journal-title":"Am J Physiol"},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jprot.2018.04.029","volume":"191","author":"C Chinello","year":"2019","unstructured":"Chinello C, Stella M, Piga I, Smith AJ, Bovo G, Varallo M, Ivanova M, Denti V, Grasso M, Grasso A et al (2019) Proteomics of liquid biopsies: depicting RCC infiltration into the renal vein by MS analysis of urine and plasma. J Proteom 191:29\u201337","journal-title":"J Proteom"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/ijc.32650","volume":"146","author":"A Di Meo","year":"2020","unstructured":"Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM (2020) Searching for prognostic biomarkers for small renal masses in the urinary proteome. Int J Cancer 146:2315\u20132325","journal-title":"Int J Cancer"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00345-022-03993-6","volume":"41","author":"P Diana","year":"2023","unstructured":"Diana P, Klatte T, Amparore D, Bertolo R, Carbonara U, Erdem S, Ingels A, Kara O, Marandino L, Marchioni M et al (2023) Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group. World J Urol 41:929\u2013940","journal-title":"World J Urol"},{"key":"498_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01965-8","volume":"8","author":"W Du","year":"2017","unstructured":"Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel CL, Puchowicz M, Serra D, Herrero L, Rini BI et al (2017) HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Nat Commun 8:1769","journal-title":"Nat Commun"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.21037\/tcr.2017.05.19","volume":"6","author":"NJ Farber","year":"2017","unstructured":"Farber NJ, Kim CJ, Modi PK, Hon JD, Sadimin ET, Singer EA (2017) Renal cell carcinoma: the search for a reliable biomarker. Transl Cancer Res 6:620","journal-title":"Transl Cancer Res"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3180001","volume":"318","author":"DR Flower","year":"1996","unstructured":"Flower DR (1996) The lipocalin protein family: structure and function. Biochem J 318:1\u201314","journal-title":"Biochem J"},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrd1199","volume":"2","author":"A Giaccia","year":"2003","unstructured":"Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2:803\u2013811","journal-title":"Nat Rev Drug Discov"},{"key":"498_CR12","first-page":"179","volume":"99","author":"RE Gray","year":"2019","unstructured":"Gray RE, Harris GT (2019) Renal cell carcinoma: diagnosis and management. Am Fam Physician 99:179\u2013184","journal-title":"Am Fam Physician"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","volume":"63","author":"AA Hakimi","year":"2013","unstructured":"Hakimi AA, Chen Y-B, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE et al (2013) Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol 63:848\u2013854","journal-title":"Eur Urol"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/nmeth.4470","volume":"14","author":"J Hartler","year":"2017","unstructured":"Hartler J, Triebl A, Ziegl A, Tr\u00f6tzm\u00fcller M, Rechberger GN, Zeleznik OA, Zierler KA, Torta F, Cazenave-Gassiot A, Wenk MR et al (2017) Deciphering lipid structures based on platform-independent decision rules. Nat Methods 14:1171\u20131174","journal-title":"Nat Methods"},{"key":"498_CR15","first-page":"1","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Prim 3:1\u201319","journal-title":"Nat Rev Dis Prim"},{"key":"498_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01745-7","volume":"22","author":"M Li","year":"2023","unstructured":"Li M, Li L, Zheng J, Li Z, Li S, Wang K, Chen X (2023) Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Mol Cancer 22:37","journal-title":"Mol Cancer"},{"key":"498_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) von Hippel-Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"key":"498_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli G, Loizzo D, Franzin R, Battaglia S, Ferro M, Cantiello F, Castellano G, Bettocchi C, Ditonno P, Battaglia M (2019) Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma. Expert Rev Mol Diagn 19:397\u2013407","journal-title":"Expert Rev Mol Diagn"},{"key":"498_CR19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966\u2013968","journal-title":"Bioinformatics"},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fphys.2018.00526","volume":"9","author":"LR Marques","year":"2018","unstructured":"Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, Lira FS, Gon\u00e7alves DC (2018) Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol. Front Physiol 9:526","journal-title":"Front Physiol"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137\u20131146","journal-title":"J Lipid Res"},{"key":"498_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","volume":"365","author":"J Mishra","year":"2005","unstructured":"Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J et al (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231\u20131238","journal-title":"Lancet"},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","volume":"48","author":"VF Muglia","year":"2015","unstructured":"Muglia VF, Prando A (2015) Renal cell carcinoma: histological classification and correlation with imaging findings. Radio Bras 48:166\u2013174","journal-title":"Radio Bras"},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41591-020-0933-1","volume":"26","author":"PV Nuzzo","year":"2020","unstructured":"Nuzzo PV, Berchuck JE, Korthauer K, Spisak S, Nassar AH, Abou Alaiwi S, Chakravarthy A, Shen SY, Bakouny Z, Boccardo F et al (2020) Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nat Med 26:1041\u20131043","journal-title":"Nat Med"},{"key":"498_CR25","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","volume":"11","author":"AC Peterson","year":"2012","unstructured":"Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ (2012) Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteom 11:1475\u20131488","journal-title":"Mol Cell Proteom"},{"key":"498_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1470-2045(22)00487-9","volume":"23","author":"T Powles","year":"2022","unstructured":"Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL et al (2022) Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis. Lancet Oncol 23:1133\u20131144","journal-title":"Lancet Oncol"},{"key":"498_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY (2024) Renal cell carcinoma: a review. JAMA 332:1001\u20131010","journal-title":"JAMA"},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"5.e11","DOI":"10.1016\/j.urolonc.2015.07.016","volume":"34","author":"V Sandim","year":"2016","unstructured":"Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB (2016) Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma. Urol Oncol 34:5.e11\u201325","journal-title":"Urol Oncol"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/cancers12010239","volume":"12","author":"L Santorelli","year":"2020","unstructured":"Santorelli L, Capitoli G, Chinello C, Piga I, Clerici F, Denti V, Smith A, Grasso A, Raimondo F, Grasso M et al (2020) In-depth mapping of the urinary N-glycoproteome: distinct signatures of ccRCC-related progression. Cancers 12:239","journal-title":"Cancers"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T, Shimamura T, Sato-Otsubo A, Nagae G, Suzuki H et al (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 45:860\u2013867","journal-title":"Nat Genet"},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1","journal-title":"Stat Appl Genet Mol Biol"},{"key":"498_CR32","first-page":"1","volume":"7","author":"K Titeca","year":"2026","unstructured":"Titeca K, Chiapparino A, Hennrich ML, T\u00fcrei D, Moqadam M, Talandashti R, Cuveillier C, van Ek L, Zukowska J, Triana S et al (2026) Systematic analyses of lipid mobilization by human lipid transfer proteins. Nat Jan 7:1\u20133","journal-title":"Nat Jan"},{"key":"498_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/labinvest.3700097","volume":"84","author":"J Tolson","year":"2004","unstructured":"Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, Kratzin H, Deeg M, Kuczyk M, Mueller GA et al (2004) Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 84:845\u2013856","journal-title":"Lab Invest"},{"key":"498_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A et al (2015) Tissue-based map of the human proteome. Science 347:1260419","journal-title":"Science"},{"key":"498_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063018","volume":"12","author":"JA Usher-Smith","year":"2022","unstructured":"Usher-Smith JA, Godoy A, Burge SW, Burbidge S, Cartledge J, Crosbie PAJ, Eckert C, Farquhar F, Hammond D, Hancock N et al (2022) The Yorkshire Kidney Screening Trial (YKST). BMJ Open 12:e063018","journal-title":"BMJ Open"},{"key":"498_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S1470-2045(22)00128-0","volume":"23","author":"Y-A Vano","year":"2022","unstructured":"Vano Y-A, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B et al (2022) Nivolumab, nivolumab\u2013ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK). Lancet Oncol 23:612\u2013624","journal-title":"Lancet Oncol"},{"key":"498_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel D, Fl\u00fcgge U (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138:141\u2013143","journal-title":"Anal Biochem"},{"key":"498_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1170567","volume":"13","author":"Y Yang","year":"2023","unstructured":"Yang Y, Pang Q, Hua M, Huangfu Z, Yan R, Liu W, Zhang W, Shi X, Xu Y, Shi J (2023) Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics. Front Oncol 13:1170567","journal-title":"Front Oncol"},{"key":"498_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P, Su F, Hosseini N, Cao X, Kumar-Sinha C et al (2021) Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA 118:e2103240118","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00498-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:37Z","timestamp":1789021897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00498-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00498-2","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IMBA has filed a European patent application (EP24190080.2) and a subsequent worldwide patent application (WO2026022127A1) based on the results presented herein. GJ, TO, and JMP are inventors on this patent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}